LinkedIn·Wednesday, 19 August 2026·7d ago
Detecting low-uptake biological signals: the NEW SPECT γ-CUBE ⬜️ Weak biological signals coming from small lesions or low-uptake targets…
Molecubes
3,567 followers
Detecting low-uptake biological signals: the NEW SPECT γ-CUBE ⬜️
Weak biological signals coming from small lesions or low-uptake targets still matter for your theranostic research.
Here is where the new γ-CUBE will make an impact:
➡️ Higher sensitivity means better signal statistics and less noise
➡️ That translates to faster acquisitions and lower injected activity
➡️ Spatial resolution is preserved. No need for trade-offs
Powered by a patent-pending UltraLofthole Collimator.
Curious how it fits your workflow? Get more information: https://lnkd.in/eMKGUSSB
♥ 31💬 1↻ 3
View on LinkedIn Cross-referenced
Related on the wire
Neuroinflammation and myelin loss in Alzheimer’s disease — how are these processes connected over time? 💡 Application in the spotlight…
Can the injected dose in SPECT be cut without losing image quality? 💡 Application in the Spotlight Reducing radiation dose in preclinical…
Advancing preclinical research with PET imaging: 💡Applications in the spotlight From inflammation targeting to neurology and drug…
From lab to clinic: closing the gap between insights and impact 🔬 Our webinar with Prof. Dr. Ken Herrmann and Prof. Dr. Katharina…
Precision medicine meets Utah’s natural beauty and urban energy 👇 Join us at the World Molecular Imaging Congress, this year in Salt Lake…
Our Applications Team is heading to Brussels this week 🔬 We’re teaming up with MITH Brussel at VUB/UZ Brussel UMCOR, Vrije Universiteit…